Ask AI
Michael R. Bishop

Michael R. Bishop, MD

Professor of Medicine
Director, The David and Etta Jonas Center for Cellular Therapy
Director, Hematopoietic Cellular Therapy Program
University of Chicago
Chicago, Illinois

Explore Activities by Michael R. Bishop

Title
Format
Credit Type
Credits
Novel ADC Therapies for R/R DLBCL: Optimizing Patient Safety With Timely AE Recognition and Management

Content Format:

PDF

Credit Type:

--

Credits:

--
Managing Relapsed/Refractory Diffuse Large B-Cell Lymphoma With ADCs: Answers to Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Experts Answer Questions on Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes

Content Format:

Slideset

Credit Type:

--

Credits:

--
Advances in CAR-T Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
ExpressPoints: Advances in CAR-T Cell Therapy Across Hematologic Malignancies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapy for Lymphomas

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
MedicalMinute: Identifying and Managing CAR T-Cell–Mediated Toxicities

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Supportive Care Considerations for CAR T-Cell Therapy: Establishing Standards of Care With the Multidisciplinary Team

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Guiding Patients and Caregivers Starting CAR T-Cell Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Slides: Identifying and Managing CAR T-Cell–Mediated Toxicities

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
MedicalMinute: Current and Near-Future CAR T-Cell Therapy Indications

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Slides: Current and Near-Future CAR T-Cell Therapy Indications

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Optimizing Collaboration, Referral, and Treatment

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints: CAR T-Cell Therapy: Optimizing Collaboration, Referral, and Treatment

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints: CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapy Against NHL and CLL: Current and Emerging Clinical Trial Evidence

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Community Oncology Best Practices in CAR T-Cell Therapy

Content Format:

Case Challenge

Credit Type:

ACPE | AMA

Credits:

1.00
Expert Guidance Frequently Asked Questions About CAR T-Cell Therapy in the Community Setting

Content Format:

Text Module

Credit Type:

--

Credits:

--
My Take on Key Studies in CAR T-Cell Therapy From ASH 2019

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25